Literature DB >> 9461098

In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity.

R Baliga1, Z Zhang, M Baliga, N Ueda, S V Shah.   

Abstract

Cisplatin is a widely used antineoplastic agent that has nephrotoxicity as a major side effect. The underlying mechanism of this nephrotoxicity is still not well known. Iron has been implicated to play an important role in several models of tissue injury, presumably through the generation of hydroxyl radicals via the Haber-Weiss reaction or other highly toxic free radicals. In the present study we examined the catalytic iron content and the effect of iron chelators in an in vitro model of cisplatin-induced cytotoxicity in LLC-PK1 cells (renal tubular epithelial cells) and in an in vivo model of cisplatin-induced acute renal failure in rats. Exposure of LLC-PK1 cells to cisplatin resulted in a significant increase in bleomycin-detectable iron (iron capable of catalyzing free radical reactions) released into the medium. Concurrent incubation of LLC-PK1 cells with iron chelators including deferoxamine and 1,10-phenanthroline significantly attenuated cisplatin-induced cytotoxicity as measured by lactate dehydrogenase (LDH) release. Bleomycin-detectable iron content was also markedly increased in the kidney of rats treated with cisplatin. Similarly, administration of deferoxamine in rats provided marked functional (as measured by blood urea nitrogen and creatinine) and histological protection against cisplatin-induced acute renal failure. In a separate study, we examined the role of hydroxyl radical in cisplatin-induced nephrotoxicity. Incubation of LLC-PK1 cells with cisplatin caused an increase in hydroxyl radical formation. Hydroxyl radical scavengers, dimethyl sulfoxide, mannitol and benzoic acid, significantly reduced cisplatin-induced cytotoxicity and, treatment with dimethyl sulfoxide or dimethylthiourea provided significant protection against cisplatin-induced acute renal failure. Taken together, our data strongly support a critical role for iron in mediating tissue injury via hydroxyl radical (or a similar oxidant) in this model of nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461098     DOI: 10.1046/j.1523-1755.1998.00767.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  63 in total

1.  Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Authors:  Navjotsingh Pabla; Guie Dong; Man Jiang; Shuang Huang; M Vijay Kumar; Robert O Messing; Zheng Dong
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  NGAL-Siderocalin in kidney disease.

Authors:  Neal Paragas; Andong Qiu; Maria Hollmen; Thomas L Nickolas; Prasad Devarajan; Jonathan Barasch
Journal:  Biochim Biophys Acta       Date:  2012-06-19

3.  Rutin Attenuates Vancomycin-Induced Nephrotoxicity by Ameliorating Oxidative Stress, Apoptosis, and Inflammation in Rats.

Authors:  Shaoqi Qu; Cunchun Dai; Fengting Lang; Longfei Hu; Qihe Tang; Haixia Wang; Yanping Zhang; Zhihui Hao
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

4.  Activation and involvement of p53 in cisplatin-induced nephrotoxicity.

Authors:  Qingqing Wei; Guie Dong; Tianxin Yang; Judit Megyesi; Peter M Price; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-01

5.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 6.  Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention.

Authors:  Shreyak Sharma; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2019-09-25       Impact factor: 10.121

7.  Radiation nephropathy is not mitigated by antagonists of oxidative stress.

Authors:  Eric P Cohen; Brian L Fish; Amy A Irving; Mohan M Rajapurkar; Sudhir V Shah; John E Moulder
Journal:  Radiat Res       Date:  2009-08       Impact factor: 2.841

8.  TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

Authors:  Ganesan Ramesh; W Brian Reeves
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Inactivation of lactate dehydrogenase by several chemicals: implications for in vitro toxicology studies.

Authors:  Derek M Kendig; Joan B Tarloff
Journal:  Toxicol In Vitro       Date:  2006-09-06       Impact factor: 3.500

10.  Stress-responsive gene TauT and acute kidney injury.

Authors:  Xiaobin Han; Russell W Chesney
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.